Practice Areas
Vincent Zhang specializes in onshore and offshore public offerings, private equity investment and financing, mergers & acquisitions, and option plan affairs. He has advised clients on a broad range of sectors and has particular expertise in advanced manufacturing, renewable energy, FMCG, semiconductors, healthcare, logistics, finance, and the environment.
Vincent has been involved in a number of remarkable projects, including: the listing of MicroPort EP Medtech (688351) on the Sci-tech Innovation Board; the secondary listing of JD.com (09618.HK); the listings of JD Health (06618.HK), JD Logistics (02618.HK), EDIANYUN (02416.HK), and GUMING (01364.HK) in Hong Kong; the listings of JINXIN Technology (NAMI) and DINGXIN Ecological Environment (DXST) on NASDAQ; the acquisition of Lion's Roar (an overseas mobile internet development and promotion enterprise) by Xunyou Technology (300467); the acquisition of the global high-end precision filament manufacturing enterprise Bode High-tech by Boway Alloy (601137); and the acquisition of the controlling stake in Deppon Logistics (603056) by JD Logistics (02618.HK).
Vincent has also been rated as a Leading Individual in Capital Markets: Debt & Equity by Chambers and Partners from 2025 to 2026, as a Key Lawyer listed in the Capital Markets category by The Legal 500 from 2022 to 2025, as an Outstanding Lawyer of The A-List in 2024 by China Business Law Journal, one of the Under 40: Top 20 New Economy Lawyers in 2023 and Top Ranked Lawyers - Capital Markets: Domestic Issuance in 2025 by LEGALBAND. In addition, he is a member of the Securities Business Research Association of the Beijing Lawyers Association and Beijing Chaoyang District Lawyers Association, advising on the decision-making process for company listings based on comprehensive analysis of multiple capital markets.